Patents by Inventor Renaud Capdeville

Renaud Capdeville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
    Publication number: 20230181529
    Abstract: Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
    Type: Application
    Filed: August 16, 2022
    Publication date: June 15, 2023
    Inventors: Rong LIN, Renaud CAPDEVILLE, Laura GRAZIOLI, Song MU, Sofia PAUL, Florence BINLICH
  • PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
    Publication number: 20200093795
    Abstract: Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
    Type: Application
    Filed: October 29, 2019
    Publication date: March 26, 2020
    Applicant: Secura Bio, Inc.
    Inventors: Rong LIN, Renaud CAPDEVILLE, Laura GRAZIOLI, Song MU, Sofia PAUL, Florence BINLICH
  • PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
    Publication number: 20190388393
    Abstract: Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
    Type: Application
    Filed: September 3, 2019
    Publication date: December 26, 2019
    Applicant: Secura Bio, Inc.
    Inventors: Rong LIN, Renaud CAPDEVILLE, Laura GRAZIOLI, Song MU, Sofia PAUL, Florence BINLICH
  • PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
    Publication number: 20190117622
    Abstract: Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 25, 2019
    Applicant: Novartis AG
    Inventors: Rong Lin, Renaud Capdeville, Laura Grazioli, Song Mu, Sofia Paul, Florence Binlich
  • PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
    Publication number: 20180028497
    Abstract: Treatment of multiple myeloma with a combination of panobinostat and bortezomib at specified doses adjusted for safety.
    Type: Application
    Filed: February 17, 2016
    Publication date: February 1, 2018
    Applicant: Novartis AG
    Inventors: Rong Lin, Renaud Capdeville, Laura Grazioli, Song Mu, Sofia Paul, Florence Binlich
  • Treatment of neuroblastoma
    Publication number: 20070135444
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutical acceptable salt thereof can be used in the treatment of neuroblastoma. The invention also relates to a combination of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutical acceptable salt thereof with one or more antineoplastic agents.
    Type: Application
    Filed: January 11, 2007
    Publication date: June 14, 2007
    Inventors: Renaud Capdeville, Valerie Combaret, Didier Frappaz, Alain Puisieux, Christophe Bergeron
  • Treatment of gastrointestinal stromal tumors
    Patent number: 6958335
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: October 25, 2005
    Assignees: Novartis AG, Dana-Farber Cancer Institute, Inc., Oregon Health & Science University
    Inventors: Elisabeth Buchdunger, Renaud Capdeville, George Daniel Demetri, Sasa Dimitrijevic, Brian Jay Druker, Jonathan A. Fletcher, Michael C. Heinrich, Heikki Joensuu, Sandra Leta Silberman, David Tuveson
  • Treatment of neuroblastoma
    Publication number: 20050159426
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutical acceptable salt thereof can be used in the treatment of neuroblastoma. The invention also relates to a combination of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutical acceptable salt thereof with one or more antineoplastic agents.
    Type: Application
    Filed: February 6, 2003
    Publication date: July 21, 2005
    Inventors: Renaud Capdeville, Valerie Combaret, Didier Frappaz, Alain Puisieux, Christophe Bergeron
  • Treatment of gastrointestinal stromal tumors
    Publication number: 20040023976
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula (I) or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
    Type: Application
    Filed: August 11, 2003
    Publication date: February 5, 2004
    Inventors: Elisabeth Buchdunger, Renaud Capdeville, George Daniel Demetri, Sasa Dimitrijevic, Brian Jay Druker, Jonathan A. Fletcher, Michael C. Heinrich, Heikki Joensuu, Sandra Leta Silberman, David Tuveson